NASDAQ:ICLR - ICON Stock Price, Price Target & More

Get Started

$126.80 +0.75 (+0.60 %)

(As of 05/22/2018 04:00 PM ET)

Previous Close$126.80

Today's Range$125.35 - $127.72

52-Week Range$85.59 - $127.72

Volume93,840 shs

Average Volume291,284 shs

Market Capitalization$6.80 billion

P/E Ratio23.53

Dividend YieldN/A

Beta0.43

About ICON (NASDAQ:ICLR)

ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. The company's clinical development services include product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk-based monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services. Its clinical development services also comprise interactive response technologies, electronic endpoint adjudication, medical imaging, adaptive trial design and execution, medical device and biosimilar trial, functional, strategic resourcing, sample analyses, safety testing, microbiology, custom flow cytometry, biomarker development, bioanalysis, immunoassay development, patient registries, outcomes research, health economics, market access and commercialization, drug price consulting, and healthcare and scientific communication services, as well as research trials for the U.S. government agencies, electronic transmission of test results, and electronic patient reported outcomes. The company was founded in 1990 and is headquartered in Dublin, Ireland.

Receive ICLR News and Ratings via Email

Sign-up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commercial physical research

Sub-IndustryN/A

SectorMedical

SymbolNASDAQ:ICLR

CUSIPN/A

Webwww.iconplc.com

Phone353-1291-2000

Debt

Debt-to-Equity Ratio0.29

Current Ratio1.85

Quick Ratio1.85

Price-To-Earnings

Trailing P/E Ratio23.53

Forward P/E Ratio20.99

P/E Growth1.98

Sales & Book Value

Annual Sales$1.76 billion

Price / Sales3.90

Cash Flow$6.6562 per share

Price / Cash19.05

Book Value$22.02 per share

Price / Book5.76

Profitability

EPS (Most Recent Fiscal Year)$5.39

Net Income$281.48 million

Net Margins14.80%

Return on Equity26.56%

Return on Assets14.53%

Miscellaneous

Employees13,250

Outstanding Shares54,080,000

ICON (NASDAQ:ICLR) Frequently Asked Questions

What is ICON's stock symbol?

ICON trades on the NASDAQ under the ticker symbol "ICLR."

How were ICON's earnings last quarter?

ICON plc (NASDAQ:ICLR) posted its quarterly earnings results on Thursday, May, 3rd. The medical research company reported $1.42 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.41 by $0.01. The medical research company had revenue of $620.13 million for the quarter, compared to the consensus estimate of $562.61 million. ICON had a net margin of 14.80% and a return on equity of 26.56%. The business's revenue was up 43.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.29 earnings per share. View ICON's Earnings History.

When is ICON's next earnings date?

ICON is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for ICON.

What guidance has ICON issued on next quarter's earnings?

ICON updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $5.91-6.11 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.99. The company issued revenue guidance of $2.52-2.64 billion, compared to the consensus revenue estimate of $2.25 billion.

What price target have analysts set for ICLR?

10 brokerages have issued 1 year price objectives for ICON's stock. Their predictions range from $114.00 to $133.00. On average, they expect ICON's stock price to reach $125.40 in the next year. View Analyst Ratings for ICON.

Who are some of ICON's key competitors?

Some companies that are related to ICON include IQVIA (IQV), Incyte (INCY), Exelixis (EXEL), EXACT Sciences (EXAS), PRA Health Sciences (PRAH), Charles River Laboratories (CRL), Syneos Health (SYNH), BTG (BTGGF), Intrexon (XON), Medpace (MEDP), National Research (NRCIB), National Research (NRCIA), Sorrento Therapeutics (SRNE), Pieris Pharmaceuticals (PIRS) and Eloxx Pharmaceuticals (ELOX).

Who are ICON's key executives?

ICON's management team includes the folowing people:

Mr. Ciaran Murray, Former Exec. Chairman (Age 55)
Dr. Steven A. Cutler, CEO & Director (Age 58)
Mr. Brendan Brennan, Chief Financial Officer (Age 39)
Jonathan Curtain, VP of Corp. Fin. & Investor Relations
Mr. Thomas O'Leary, Chief Information Officer

Has ICON been receiving favorable news coverage?

News articles about ICLR stock have trended somewhat positive on Tuesday, according to Accern. The research group scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ICON earned a media sentiment score of 0.09 on Accern's scale. They also gave media headlines about the medical research company an impact score of 46.42 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are ICON's major shareholders?

ICON's stock is owned by a variety of of institutional and retail investors. Top institutional investors include WCM Investment Management CA (8.25%), Earnest Partners LLC (4.01%), Wasatch Advisors Inc. (3.07%), Boston Partners (3.01%), Wells Fargo & Company MN (1.93%) and Principal Financial Group Inc. (1.75%). View Institutional Ownership Trends for ICON.

Which institutional investors are selling ICON stock?

ICLR stock was sold by a variety of institutional investors in the last quarter, including Westfield Capital Management Co. LP, Earnest Partners LLC, Envestnet Asset Management Inc., Wasatch Advisors Inc., Victory Capital Management Inc., Fiera Capital Corp, Wells Fargo & Company MN and Loomis Sayles & Co. L P. View Insider Buying and Selling for ICON.

Which institutional investors are buying ICON stock?

ICLR stock was acquired by a variety of institutional investors in the last quarter, including Boston Partners, WCM Investment Management CA, Principal Financial Group Inc., Principal Financial Group Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, American Century Companies Inc. and Baird Financial Group Inc.. View Insider Buying and Selling for ICON.

How do I buy shares of ICON?

Shares of ICLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ICON's stock price today?

One share of ICLR stock can currently be purchased for approximately $126.80.

How big of a company is ICON?

ICON has a market capitalization of $6.80 billion and generates $1.76 billion in revenue each year. The medical research company earns $281.48 million in net income (profit) each year or $5.39 on an earnings per share basis. ICON employs 13,250 workers across the globe.

How can I contact ICON?

ICON's mailing address is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. The medical research company can be reached via phone at 353-1291-2000.

MarketBeat Community Rating for ICON (ICLR)

Community Ranking:		2.9 out of 5 ( )
Outperform Votes:		357 (Vote Outperform)
Underperform Votes:		266 (Vote Underperform)
Total Votes:		623

MarketBeat's community ratings are surveys of what our community members think about ICON and other stocks. Vote "Outperform" if you believe ICLR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICLR will underperform the S&P 500 over the long term. You may vote once every thirty days.

ICON (NASDAQ:ICLR) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

10 Wall Street analysts have issued ratings and price targets for ICON in the last 12 months. Their average twelve-month price target is $125.40, suggesting that the stock has a possible downside of 1.10%. The high price target for ICLR is $133.00 and the low price target for ICLR is $114.00. There are currently 2 hold ratings, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.90	2.90	2.90	2.90
Ratings Breakdown:	0 Sell Rating(s) 2 Hold Rating(s) 7 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 7 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 7 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 7 Buy Rating(s) 1 Strong Buy Rating(s)
Consensus Price Target:	$125.40	$125.40	$125.40	$120.30
Price Target Upside:	1.10% downside	10.14% upside	10.14% upside	5.70% upside

ICON (NASDAQ:ICLR) Consensus Price Target History

Price Target History for ICON (NASDAQ:ICLR)

ICON (NASDAQ:ICLR) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/16/2018	Credit Suisse Group	Upgrade	Buy	$131.00	Low
2/15/2018	Mizuho	Reiterated Rating	Neutral ➝ Neutral	$109.00 ➝ $114.00	Low
1/22/2018	SunTrust Banks	Reiterated Rating	Buy	$133.00	Low
1/18/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$126.00	High
1/11/2018	KeyCorp	Reiterated Rating	Buy	$130.00	Medium
10/27/2017	Barclays	Boost Price Target	Equal Weight ➝ Equal Weight	$108.00 ➝ $120.00	N/A
10/12/2017	Robert W. Baird	Reiterated Rating	Buy	$123.00	N/A
10/9/2017	Jefferies Group	Boost Price Target	Buy	$122.00 ➝ $132.00	N/A
9/11/2017	Bank of America	Initiated Coverage	Buy ➝ Buy	$128.00	Low
7/7/2017	Goldman Sachs	Upgrade	Buy ➝ Conviction-Buy	$117.00	High
10/20/2016	Avondale Partners	Upgrade	Underperform ➝ Market Perform		N/A

(Data available from 5/22/2016 forward)

ICON (NASDAQ:ICLR) Earnings History and Estimates Chart

Earnings by Quarter for ICON (NASDAQ:ICLR)

ICON (NASDAQ:ICLR) Earnings Estimates

2018 EPS Consensus Estimate: $6.03
2019 EPS Consensus Estimate: $6.74

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	5	$1.37	$1.44	$1.40
Q2 2018	5	$1.47	$1.53	$1.49
Q3 2018	5	$1.51	$1.58	$1.55
Q4 2018	5	$1.54	$1.65	$1.60
Q1 2019	1	$1.59	$1.59	$1.59
Q2 2019	1	$1.65	$1.65	$1.65
Q3 2019	1	$1.70	$1.70	$1.70
Q4 2019	1	$1.80	$1.80	$1.80

ICON (NASDAQ ICLR) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/26/2018
5/3/2018	3/31/2018	$1.41	$1.42	$562.61 million	$620.13 million	View	N/A
2/15/2018	Not Specified	$1.41	$1.43	$455.66 million	$455.10 million	View	N/A
10/26/2017	9/30/2017	$1.32	$1.35	$438.09 million	$440.30 million	View	N/A
7/27/2017	6/30/2017	$1.30	$1.31	$430.68 million	$431.00 million	View	N/A
4/27/2017	3/31/2017	$1.27	$1.29	$432.21 million	$432.00 million	View	N/A
2/16/2017	Q416	$1.26	$1.33	$440.78 million	$435.00 million	View	Listen
10/20/2016	Q316	$1.18	$1.19	$420.14 million	$420.20 million	View	Listen
7/26/2016	Q216	$1.14	$1.14	$409.97 million	$411.00 million	View	Listen
4/26/2016	Q116	$1.11	$1.12	$414.35 million	$400.50 million	View	Listen
2/23/2016	Q415	$1.10	$1.11	$409.42 million	$403.00 million	View	Listen
10/27/2015	Q315	$1.01	$1.02	$399.02 million	$394.70 million	View	Listen
7/28/2015	Q215	$0.90	$0.95	$402.15 million	$389.00 million	View	Listen
4/28/2015	Q115	$0.81	$0.90	$391.11 million	$388.00 million	View	N/A
2/25/2015	Q4	$0.76	$0.87	$391.37 million	$390.10 million	View	N/A
10/22/2014	Q314	$0.70	$0.79	$391.12 million	$388.00 million	View	Listen
7/30/2014	Q2	$0.58	$0.64	$376.89 million	$376.00 million	View	Listen
4/30/2014	Q1	$0.50	$0.57	$352.14 million	$350.00 million	View	Listen
2/20/2014	Q413	$0.45	$0.53	$339.86 million	$345.00 million	View	Listen
10/24/2013	Q313	$0.41	$0.45	$332.58 million	$339.80 million	View	Listen
7/25/2013	Q2 2013	$0.38	$0.43	$321.82 million	$334.20 million	View	Listen
4/25/2013	Q1 2013	$0.34	$0.36	$300.81 million	$317.00 million	View	Listen
2/19/2013	Q4 2012	$0.33	$0.34	$291.96 million	$300.00 million	View	Listen
11/1/2012	Q312	$0.27	$0.29	$282.67 million	$286.00 million	View	N/A
7/24/2012		$0.22	$0.21			View	N/A
4/24/2012		$0.15	$0.15			View	N/A
2/16/2012		$0.08	$0.07			View	N/A
10/27/2011		$0.02	$0.02			View	N/A
7/20/2011		$0.22	$0.21			View	N/A
4/21/2011		$0.21	$0.21			View	N/A
2/24/2011		$0.36	$0.36			View	N/A
10/21/2010	Q3 2010	$0.37	$0.33			View	N/A
7/27/2010	Q2 2010	$0.37	$0.38			View	N/A
4/27/2010	Q1 2010	$0.36	$0.37			View	N/A
2/25/2010	Q4 2009	$0.38	$0.40			View	N/A
10/21/2009	Q3 2009	$0.35	$0.40			View	N/A
7/22/2009	Q2 2009	$0.34	$0.38			View	N/A
4/28/2009	Q1 2009	$0.34	$0.35			View	N/A
2/23/2009	Q4 2008	$0.34	$0.35			View	N/A
10/21/2008	Q3 2008	$0.32	$0.35			View	N/A
7/22/2008	Q2 2008	$0.30	$0.31			View	N/A
4/29/2008	Q1 2008	$0.27	$0.28			View	N/A
2/21/2008	Q4 2007	$0.25	$0.27			View	N/A

(Earnings results data provided by Zacks Investment Research)

ICON (NASDAQ:ICLR) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

ICON (NASDAQ ICLR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 44.00%
Institutional Ownership Percentage: 89.28%

Insider Trading History for ICON (NASDAQ:ICLR)

Institutional Ownership by Quarter for ICON (NASDAQ:ICLR)

ICON (NASDAQ ICLR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details

(Data available from 1/1/2013 forward)

ICON (NASDAQ ICLR) News Headlines

Source:

Date	Headline
	The Red Phone Box, a British Icon, Stages a Comeback www.nytimes.com - May 22 at 4:58 PM
	Icon Global Announces Streamlined Sales Process For $250 Million Sandow Lakes Facility In Central Texas www.prnewswire.com - May 22 at 8:34 AM
	Janet Jackson's Billboard Music Icon Award is a career-affirming moment for an underrated superstar www.nbcnews.com - May 22 at 8:34 AM
	Janet Jackson becomes first black woman to receive the Billboard Icon Award www.usatoday.com - May 21 at 4:59 PM
	BRIEF-Icon To Cut Administrative Costs And Raise Regulatory Compliance www.reuters.com - May 21 at 8:33 AM
	ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase Regulatory Compliance finance.yahoo.com - May 21 at 8:33 AM
	Civil rights icon, Trump critic highlighting BU commencement abcnews.go.com - May 20 at 8:41 AM
	Kiss Icon Gene Simmons: Tesla CEO Elon Musk Is a Rock Star www.thestreet.com - May 18 at 9:06 AM
	ICON (ICLR) Downgraded by BidaskClub www.americanbankingnews.com - May 17 at 5:47 PM
	Saama Technologies and ICON Commercialization and Outcomes Partner to Unlock the Value of Real World Evidence (RWE) finance.yahoo.com - May 15 at 8:53 AM
	ICON Announces Clinical Research partnership with DuPage Medical Group finance.yahoo.com - May 14 at 8:57 AM
	ICON plc (ICLR) Given Average Recommendation of "Buy" by Brokerages www.americanbankingnews.com - May 14 at 1:30 AM
	Head to Head Analysis: Senomyx (SNMX) vs. ICON (ICLR) www.americanbankingnews.com - May 11 at 7:35 PM
	Tim Draper says Theranos founder charged with fraud is an 'icon' who did 'a great job' www.marketwatch.com - May 11 at 8:59 AM
	ICON Sponsors Industry-Wide Clinical Trials Survey to Support Transforming Trials Initiative finance.yahoo.com - May 9 at 8:42 AM
	Janet Jackson To Receive Icon Award At 2018 Billboard Music Awards www.huffingtonpost.com - May 8 at 5:18 PM
	ICON (ICLR) Upgraded at Zacks Investment Research www.americanbankingnews.com - May 8 at 3:23 PM
	Icon PLC Enjoying Wall Street Bonanza And FDA Tailwind seekingalpha.com - May 7 at 5:21 PM
	Janet Jackson to perform, receive Icon honor at the Billboard Awards www.usatoday.com - May 7 at 5:21 PM
	ICON plc Forecasted to Earn FY2019 Earnings of $6.84 Per Share (ICLR) www.americanbankingnews.com - May 7 at 5:01 AM
	Late TV icon Steven Bochco is honored with Fox Studios building, the 'epicenter' of his hit shows www.latimes.com - May 6 at 8:42 AM
	Iconix Brand Group's (ICON) CEO John Haugh on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 5 at 5:20 PM
	ICON (ICLR) Announces Earnings Results www.americanbankingnews.com - May 4 at 8:33 PM
	Analysts Offer Predictions for ICON plc's Q1 2019 Earnings (ICLR) www.americanbankingnews.com - May 4 at 9:47 AM
	ICON (ICLR) Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 4 at 8:35 AM
	Edited Transcript of ICLR earnings conference call or presentation 3-May-18 1:00pm GMT finance.yahoo.com - May 4 at 8:35 AM
	KeyCorp Research Analysts Increase Earnings Estimates for ICON plc (ICLR) www.americanbankingnews.com - May 4 at 6:47 AM
	ICON (ICLR) Raised to Buy at BidaskClub www.americanbankingnews.com - May 3 at 11:15 PM
	How 'Cobra Kai' paid tribute to 'Karate Kid' icon Pat Morita aka Mr. Miyagi abcnews.go.com - May 3 at 5:09 PM
	Bob Dylan & Whiskey: Music Icon Wins Rave Reviews For His Luxury Spirits www.forbes.com - May 3 at 8:34 AM
	Icon PLC: 1Q Earnings Snapshot finance.yahoo.com - May 3 at 8:34 AM
	Analysts Anticipate ICON plc (ICLR) Will Post Quarterly Sales of $619.48 Million www.americanbankingnews.com - May 3 at 2:30 AM
	ICON (ICLR) Updates FY18 Earnings Guidance www.americanbankingnews.com - May 2 at 5:46 PM
	China Takes On Peppa Pig, Unlikely Rebel Icon www.nytimes.com - May 2 at 5:19 PM
	ICON Reports First Quarter 2018 Results finance.yahoo.com - May 2 at 5:19 PM
	$1.41 EPS Expected for ICON plc (ICLR) This Quarter www.americanbankingnews.com - May 1 at 7:14 PM
	'RBG': How Ruth Bader Ginsburg became a legit pop-culture icon www.usatoday.com - May 1 at 5:04 PM
	Critical Survey: ICON (ICLR) & IQVIA (IQV) www.americanbankingnews.com - May 1 at 1:03 PM
	This is everything tennis icon Roger Federer eats and drinks for breakfast, lunch, and dinner www.businessinsider.com - April 30 at 8:42 AM
	Ram, Harman Kardon Enlist Nashville Icon Dave Cobb To Fine-Tune Audio In Cab of New 1500 www.forbes.com - April 29 at 8:46 AM
	NBC News icon Tom Brokaw rebuts sex harassment accuser in searing email: 'I was ambushed' www.foxnews.com - April 27 at 5:03 PM
	CNBC'S “WARREN BUFFETT: INVESTOR. TEACHER. ICON.” TO PREMIERE FRIDAY, MAY 4 AT 10PM ET/PT www.cnbc.com - April 26 at 5:04 PM
	Pantera CEO Says Bitcoin Is 'Screaming Buy,' Bets on Icon www.bloomberg.com - April 26 at 5:04 PM
	The single-family house: An American icon faces an uncertain future www.usatoday.com - April 26 at 8:32 AM
	Basketball Icon Stephon Marbury Joins China's Sun Seven Stars' New Sports Blockchain Group, Inks Deal with World's ... globenewswire.com - April 26 at 8:32 AM
	ICON (ICLR) to Release Earnings on Thursday www.americanbankingnews.com - April 26 at 3:10 AM
	Kanye tweets right -- What happens when a hip hop icon takes the red pill and dares to challenge liberals www.foxnews.com - April 25 at 5:16 PM
	See what the IHS Markit Score report has to say about ICON PLC. finance.yahoo.com - April 25 at 8:35 AM
	Comparing Luna Innovations (LUNA) & ICON (ICLR) www.americanbankingnews.com - April 24 at 5:30 PM
	Your Next Home Could Be 3D-Printed fortune.com - April 23 at 8:29 AM